1. Andreassen, A., Oyjord, T., Hovig, E., Holm, R., Florenes, V. A., Nesland, J. M., Myklebost, O. & Hoie, J. (1993). p53 abnormalities in different sub-types of human sarcomas. Cancer Res 53: 468–471.
2. Buckbinder, L., Talbott, R., Velasco, M. S., Takenaka, I., Faha, B., Seizinger, B. R. & Kley, N. (1995). Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 377: 646–649.
3. Castresana, J. S., Barrios, C., Gómez, L. & Kreicbergs, A. (1994). No association between c-myc amplification and tp53 mutation in sarcoma tumorigenesis. Cancer Genet Cytogenet 76: 47–49.
4. Castresana, J. S., Rubio, M-P, Gómez, L., Kreicbergs, A., Zetterberg, A. & Barrios, C. (1995). Detection of tp53 gene mutations in human sarcomas. Eur J Cancer 31A: 735–738.
5. Cordon-Cardo, C., Latres, E., Drobnjak, M., Oliva, M., Pollack, D., Woodruff, J. M., Marechal, V., Chen, J., Brennan, M. F. & Levine, A. J. (1994). Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas. Cancer Res 54: 794–799.